Cetirizine Hydrochloride Oral Solution
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
83745-185 -
Package NDC
83745-185-04 -
Package NDC
83745-185-08 -
Package NDC
83745-185-16 -
Application number
ANDA078870 -
SPL ID
b350aaa9-197e-4ebc-8315-6ea307dcdb2e -
SPL set ID
9c6a440b-bd0f-414b-bab3-3b2f57c479d7 -
UNII
64O047KTOA -
RxCUI
1014673
What the source publishes
- Labeler
- APOZEAL PHARMACEUTICALS INC
- Active ingredients
- Cetirizine Hydrochloride Oral Solution
- Form
- SOLUTION
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Cetirizine Hydrochloride Oral Solution",
"splId": "b350aaa9-197e-4ebc-8315-6ea307dcdb2e",
"labels": [
{
"setId": "9c6a440b-bd0f-414b-bab3-3b2f57c479d7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c6a440b-bd0f-414b-bab3-3b2f57c479d7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=9c6a440b-bd0f-414b-bab3-3b2f57c479d7"
}
],
"routes": [
"ORAL"
],
"labeler": "APOZEAL PHARMACEUTICALS INC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "120 mL in 1 BOTTLE (83745-185-04)",
"package_ndc": "83745-185-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20241220"
},
{
"sample": false,
"description": "240 mL in 1 BOTTLE (83745-185-08)",
"package_ndc": "83745-185-08",
"identifierStatus": "well-formed",
"marketing_start_date": "20241220"
},
{
"sample": false,
"description": "480 mL in 1 BOTTLE (83745-185-16)",
"package_ndc": "83745-185-16",
"identifierStatus": "well-formed",
"marketing_start_date": "20241220"
}
],
"productId": "83745-185_b350aaa9-197e-4ebc-8315-6ea307dcdb2e",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "83745-185",
"deaSchedule": null,
"genericName": "Cetirizine Hydrochloride Oral Solution",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CETIRIZINE HYDROCHLORIDE",
"strength": "1 mg/mL"
}
],
"applicationNumber": "ANDA078870",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20241220",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0383745185042",
"0383745185165",
"0383745185080"
],
"unii": [
"64O047KTOA"
],
"rxcui": [
"1014673"
],
"spl_set_id": [
"9c6a440b-bd0f-414b-bab3-3b2f57c479d7"
],
"manufacturer_name": [
"APOZEAL PHARMACEUTICALS INC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:83745-185_b350aaa9-197e-4ebc-8315-6ea307dcdb2e"